Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.

Purpose: To date there has not been an extensive analysis of the outcomes of biomarker use in oncology.

Methods: Data were pooled across four indications in oncology drawing upon trial outcomes from www.clinicaltrials.